Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
作者信息
Walker S, Groom G, Davis R H, Hibbard B M, Griffiths K
出版信息
Lancet. 1975 Nov 1;2(7940):842-4. doi: 10.1016/s0140-6736(75)90235-4.
PMID:53330
Abstract
2-bromo-alpha-ergocryptine (bromocriptine) in a dosage of 2-5 mg twice daily caused a rapid fall in plasma prolactin. It was more effective than either a single dose of 4 mg quinoestrol or a placebo in suppressing puerperal lactation, as judged by milk flow and the relief of breast pain and congestion. Patients who received quinoestrol were more comfortable than those who received placebo.
摘要
Zotero 插件